Clearside Biomedical Inc. held its annual meeting of stockholders on May 30, 2025. During the meeting, stockholders elected three nominees, George Lasezkay, Christy L. Shaffer, and Anthony S. Gibney, to the board of directors. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, an amendment to the company's Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000 was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearside Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-079689), on May 30, 2025, and is solely responsible for the information contained therein.